Uncovering the molecular machinery driving caspase-2 activation
Uncovering the molecular machinery driving caspase-2 activation
批准号:
235195892
负责人:
Professor Dr. Krishnaraj Rajalingam
金额:
$0.0万
依托单位国家:
德国
项目类别:
Research Grants
财政年份:
2013
资助国家:
德国
项目状态:
已结题
起止时间:
2012-12-31 至 2015-12-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Apoptosis is a form of programmed cell death characterized by unique morphological and biochemical features including activation of proteases called caspases, which are classified into initiator and effector caspases. Initiator caspases are recruited to multimeric protein complexes for their dimerization and activation. Caspase-2 is a unique member of the caspase family as it exhibits features of both initiator and effector caspases. Despite being the first cloned mammalian caspase the role of caspase-2 remained enigmatic and the unique apoptotic stimuli that activate caspase-2 as an initiator caspase remained unknown. We have uncovered that caspase-2 is activated as an initiator caspase during Pore forming toxins (PFTs)-mediated apoptosis. PFTs (for instance alpha-hemolysin and aerolysin) are major bacterial virulence factors secreted by pathogenic bacteria and they elicit cytotoxic effects primarily by forming pores on the host cell membranes. We have sown that caspase-2 is required for mediating both alpha-hemolysin and aerolysin-mediated apoptosis in human epithelial cells. Caspase-2 is activated in a PIDDosome independent manner and by employing high-resolution gel filtration chromatography, we have identified that caspase-2 is recruited to a novel high molecular weight complex (Castosome) in PFT-treated cells. Recruitment of caspase-2 to this high molecular weight complex and its activation are dependent on PFT-induced potassium efflux thus revealing a crucial role for potassium ions in regulating caspase-2 activation. We aim to decipher the components of castosome complex and further elucidate mechanisms behind caspase-2 activation. These results will enable us to design rational therapeutic drugs to combat several bacterial infections and cancer.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
Characterizing plasma membrane-associated prohibitins in the regulation of RAS activation and tumourigenesis
-
批准号:417198367
-
项目类别:Research Grants
-
资助金额:$0.0万
-
财政年份:2019
-
负责人:Professor Dr. Krishnaraj Rajalingam
-
依托单位:
Understanding the molecular machinery driving basic cellular processes with relevance to the pathogenesis of cancer and auto immune disorders
-
批准号:250873790
-
项目类别:Heisenberg Professorships
-
资助金额:$0.0万
-
财政年份:2014
-
负责人:Professor Dr. Krishnaraj Rajalingam
-
依托单位:
Modulation of cell survival by prohibitin and IAP-IAP complexes
-
批准号:49127547
-
项目类别:Independent Junior Research Groups
-
资助金额:$0.0万
-
财政年份:2007
-
负责人:Professor Dr. Krishnaraj Rajalingam
-
依托单位:
国内基金
海外基金
登录
查看更多内容
配子生成素GGN不同位点突变损伤分子伴侣BIP及HSP90B1功能导致精子形成障碍的发病机理
-
批准号:82371616
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:姚晨成
-
依托单位:
MYRF/SLC7A11调控施万细胞铁死亡在三叉神经痛脱髓鞘病变中的作用和分子机制研究
-
批准号:82370981
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:陈敏洁
-
依托单位:
PET/MR多模态分子影像在阿尔茨海默病炎症机制中的研究
-
批准号:82372073
-
项目类别:面上项目
-
资助金额:48.00万元
-
批准年份:2023
-
负责人:张淼
-
依托单位:
GREB1突变介导雌激素受体信号通路导致深部浸润型子宫内膜异位症的分子遗传机制研究
-
批准号:82371652
-
项目类别:面上项目
-
资助金额:45.00万元
-
批准年份:2023
-
负责人:刘开江
-
依托单位:
靶向PARylation介导的DNA损伤修复途径在恶性肿瘤治疗中的作用与分子机制研究
-
批准号:82373145
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:历鹏
-
依托单位:
OBSL1功能缺失导致多指(趾)畸形的分子机制及其临床诊断价值
-
批准号:82372328
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:项盈
-
依托单位:
O6-methyl-dGTP抑制胶质母细胞瘤的作用及分子机制研究
-
批准号:82304565
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:李瑾
-
依托单位:
转录因子LEF1低表达抑制HMGB1致子宫腺肌病患者子宫内膜容受性低下的分子机制
-
批准号:82371704
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2023
-
负责人:徐步芳
-
依托单位:
Irisin通过整合素调控黄河鲤肌纤维发育的分子机制研究
-
批准号:32303019
-
项目类别:青年科学基金项目
-
资助金额:30.00万元
-
批准年份:2023
-
负责人:职韶阳
-
依托单位:
上皮细胞黏着结构半桥粒在热激保护中的作用机制研究
-
批准号:31900545
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2019
-
负责人:傅容
-
依托单位: